Trial intelligence / Profile preview

Carvedilol for Exercise Performance in Fontan Patients

NCT02946892Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Nov 2016
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of carvedilol in Fontan circulation, sponsored by UT Southwestern Medical Center. Started Nov 2016; status: completed.

02

Drugs

carvedilol
03

Conditions

Fontan circulation

Beyond the preview

Go deeper on NCT02946892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02946892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call